SaraSmallMD
@SaraSmallMD1
Followers
172
Following
211
Media
3
Statuses
19
Assistant professor at Fox Chase Cancer Center. Physician Scientist. Leukemia researcher.
Chicago, IL
Joined April 2020
A great group of fellows – we were thrilled to welcome them to the White Oak Campus for #ProjectODACOdyssey! Thank you to @AACR for your collaboration! #OCEProjectSocrates @drjennifergao @realrickpazdur Next application period opens 6/1. Bookmark this🔽 https://t.co/TrMIsCDQWq
2
9
27
Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation | PNAS
pnas.org
Allogeneic hematopoietic cell transplantation (HCT) provides effective treatment for hematologic malignancies and immune disorders. Monitoring of p...
3
16
77
Don’t miss this week’s new issue of Science Signaling! A “master” cytokine coordinates how cells respond to DNA damage, how naïve T cells survive in the periphery, interrogating synaptic transmission in the mouse brain, and more! https://t.co/dDCfUNe6GT
0
3
7
The Brown lab discovers that IL-19 acts as a “master” #cytokine that triggers proinflammatory cytokine secretion in cells responding to DNA damage from ionizing radiation, chemotherapy, and other insults. @PennCancer #Inflammation
https://t.co/KKawpqMSXM
0
1
4
Changes in BCL-2 family members in response to ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in pts with CLL and provides a biological rationale for combination of these two agents: https://t.co/urFQbn1EJ5
#leusm #hemeonc
0
8
10
Assessment of N95 respirator decontamination and re-use for SARS-CoV-2
medrxiv.org
The unprecedented pandemic of COVID-19 has created worldwide shortages of personal protective equipment, in particular respiratory protection such as N95 respirators[1][1]. SARS-CoV-2 transmission is...
0
0
1
Acalabrutinib COVID-19 Trial Launching https://t.co/SZ05jTbLWc via @onclive
0
0
2